Nalaganje...
Landmark Studies Impacting the Medical Management of Benign Prostatic Hyperplasia
The treatment of benign prostatic hyperplasia (BPH) has changed dramatically over the past 10 years. Phase 3 studies of the safety and effectiveness of α-blockers (eg, terazosin and doxazosin) and 5-α-reductase inhibitors (eg, finasteride) for the treatment of BPH began to appear in the literature i...
Shranjeno v:
| Glavni avtor: | |
|---|---|
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
MedReviews, LLC
2003
|
| Teme: | |
| Online dostop: | https://ncbi.nlm.nih.gov/pmc/articles/PMC1502353/ https://ncbi.nlm.nih.gov/pubmed/16985962 |
| Oznake: |
Označite
Brez oznak, prvi označite!
|